You are here

Cell Transplantation

eISSN: 15553892 | ISSN: 09636897 | Current volume: 32 | Current issue: 1 Frequency: Yearly

Cell Transplantation

Impact Factor: 3.3

Indexed In: CABI: CAB Abstracts, CABI: Global Health, Clarivate Analytics: BIOSIS Previews, Clarivate Analytics: Current Contents - Life Sciences, Clarivate Analytics: Science Citation Index, Clarivate Analytics: Science Citation Index Expanded, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), PubMed: MEDLINE, SCOPUS

Cell Transplantation is a peer-reviewed open access journal which focusses on cell transplantation and its applications.

This journal is a member of the Committee on Publication Ethics (COPE).

Submission information

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Open access article processing charge (APC) information

Publication is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence. The APC for this journal is currently $2650 USD. Commentary Is free of charge

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Please direct any queries to

Cell Transplantation is an international forum for research into cell transplantation and its applications. It is an open access, peer-reviewed journal that publishes high-quality articles dealing with a wide range of basic research and clinical study topics in the field.

Topics covered include but are not limited to:
• The physiological, medical, preclinical, tissue engineering
• Device-oriented aspects of the nervous, endocrine, and endothelial systems
• The application of cell therapy/transplantation in diseases
• Stem cell differentiation, proliferation, and migration
• Stem cell therapy/transplantation and regenerative medicine
• Immunology in cell-based therapy/transplantation
• Synthetic biology in cell-based therapy/transplantation
• Biophysics and mechanobiology in cell-based therapy/transplantation
• Cell-based drug delivery
• Tissue or organ regeneration/Transplantation
• Biomaterials and regeneration/transplantation
• Relevant technological advances, patents, and ethical and regulatory considerations of the implantation of cells into the body

Paul R. Sanberg University of South Florida Morsani College of Medicine, USA
Shinn-Zong Lin Tzu Chi University, Taiwan
Deputy Editor-in-Chief
Ying Lou, PhD SAGE Publishing, China
Cardiovascular System, Skin, and Other Tissues
Jinghai Chen Zhejiang University, China
Nelson A. Hossne, Jr. Federal University of São Paulo, Brazil
Ren Ke Li University of Toronto, Canada
Kai Wang Department of Physiology, Peking University, China
Lauren E. Woodard Vanderbilt University, USA
Zhicao Yue Shenzhen University, China
Roberto Gramignoli Karolinska Insitutet, Sweden
Zhiying He Tongji University, China
Ewa Ellis Karolinska Institute, Sweden
Ira Fox University of Pittsburgh, USA
Toshihiro Mitaka Sapporo Medical University, Japan
Islets and Other Endocrines
Rodolfo Alejandro University of Miami School of Medicine, USA
Federico Bertuzzi Ospedale Niguarda Cà Granda, Italy
Hidetaka Hara Yunnan Agricultural University, China
Hirotake Komatsu City of Hope, USA
Haisong Liu Hunan University, China
Klearchos K. Papas University of Arizona, USA
Lorenzo Piemonti San Raffaele Scientific Institute, Italy
Michael R. Rickels University of Pennsylvania, USA
Naoaki Sakata Fukuoka University, Japan
Xi Wang Peking University, China
Gordon C. Weir Joslin Diabetes Center, USA
Methods and New Technologies
Xin-Xin Han Fudan University, China
Jimin Shi Zhejiang University, China
Evan Y. Snyder Burnham Institute for Medical Research, USA
Peggy Stock University of Leipzig, Germany
Tao Tan Kunming University of Science and Technology, China
Microbiome and Emerging Technologies
Ganzhu Feng The second affiliated hospital of Nanjing Medical University, China
Zongxin Ling Zhejiang University, China
Yanmin Zhao Zhejiang University, China
Muscle, Bone, and Cartilage
Negar Azarpira Shiraz University of Medical Sciences, Iran
Honghao Hou Southern Medical University, China
Xinqi Huang Sichuan University, China
Chunyi Li Changchun Sci-Tech University, China
Neuroscience and Tissue Engineering
Ernest Arenas Karolinska Institute, Sweden
Johannes Boltze University of Warwick, UK
Isao Date Okayama University, Japan
Mari Dezawa Tohoku University, Japan
Gary Dunbar Central Michigan University, USA
John Elsworth Yale University, USA
David Eve University of South Florida, United States
Ji-Feng Fei Southern Medical University, China
Thomas B. Freeman University of South Florida, USA
Monte A. Gates University of Keele, UK
Hideki Hida Nagoya City University, Japan
Stuart I. Hodgetts University of Western Australia, Australia
Kyung-Sun Kang Seoul National University, Korea
Robert S. Langer Massachusetts Institute of Technology, USA
Xiaohong Li Medical School of Tianjin University, China
Yan Liu Nanjing Medical University, China
Walter Low University of Minnesota, USA
Kwok-Fai So University of Hong Kong, Hong Kong
Yun Wang National Institute on Drug Abuse, NIH, USA
Takao Yasuhara Okayama University, Japan
Lyandysha Viktorovna Zholudeva Gladstone Institutes, USA
Pain Medicine
Jianguo Cheng Cleveland Clinic, USA
Alan D. Kaye Louisiana State University School of Medicine, USA
Giustino Varrassi Paolo Procacci Foundation, Rome, Italy
Stem Cells, Progenitors, and Bone Marrow
Francesca Cicchetti CHUL, Canada
Umberto Galderisi Luigi Vanvitelli Campania University, Italy
Jianyong Han China Agricultural University, China
Yongxian Hu Zhejiang University, China
Guoqiang Hua Fudan University, China
Antonio Ibarra Universidad Anáhuac México Norte, Mexico
Kyu-Shik Jeong Kyungpook National University, Korea
Ling Li Beckman Research Institute of City of Hope, USA
Yi Luo Zhejiang University, China
Manash Paul University of California-Los Angeles, USA
Jun Wang Shanghai Jiao Tong University School of Medicine, China
Ren-He Xu University of Macau, China
Bing Zhao Fudan University, Shanghai, China
Yun Zhao Soochow University, China
Translational Science
Mitchell S. Cairo New York Medical College, USA
Zhaohui Gong Ningbo University School of Medicine, Zhejiang, China
Horng-Jyh Harn Hualien Tzu Chi Hospital, Taiwan
Bin Li Shanghai Jiao Tong University, China
Greg Nowak Karolinska Institute, Sweden
Dario Siniscalco Second University of Naples, Italy
Hong-Lin Su National Chung Hsing University, Taiwan
Junjie Xiao Shanghai University, China
Wise Young Rutgers State University of New Jersey, USA
Founding Editors
Founding Editor: Paul R. Sanberg University of South Florida Morsani College of Medicine, USA
Co-Founding Editor: Camillo Ricordi University of Miami, USA
  • CABI: CAB Abstracts
  • CABI: Global Health
  • Clarivate Analytics: BIOSIS Previews
  • Clarivate Analytics: Current Contents - Life Sciences
  • Clarivate Analytics: Science Citation Index Expanded
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • ProQuest
  • PubMed Central (PMC)
  • PubMed: MEDLINE


Before you submit your research, please make sure your paper meets the below criteria:

  1. Your paper is an original work and has not been published or currently under review with another journal.

  2. Only authors that have contributed to the work are added. Please see ICMJE's guidelines "Defining Roles of Authors and Contributors". 

  3. Your work meets all Research Ethics and Reporting Standards. 

  4. Your figures are of acceptable quality and uploaded as separate files. Line art should be 900-1200 DPI, images 300 DPI. Images should be minimally processes to uphold their original integrity. More figure information here. Please consult our guidance on gels and blots here

  5. Your references are formatted correctly and numbered as they appear in the text. Please see here for reference style.  

  6. Data and complete methods should be made available so that others may replicate your study. If applicable, please see here for more information and data repositories.  

  7. Authors must have an understanding and agreement to pay any applicable article processing charges (APCs).

  8. Only manuscripts of sufficient quality that meet the aims & scope of the journal will be reviewed.

  9. Full guidelines are below. Submissions that don't adhere to these instructions will be returned prior to peer review. 

Once your manuscript meets all criteria above and below, you can submit it through our online submission system here.

Please note: The APC for CLL is $2650 USD. 

This Journal is a member of the Committee on Publication Ethics. This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).


This Journal is a member of the Committee on Publication Ethics.

This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to
Biomedical Journals
formulated by the International Committee of Medical Journal Editors (ICMJE).

Sage Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

Please include a cover letter, containing the name, full mailing address, telephone, email address and fax number (if applicable) of the author responsible for correspondence. Follow the Preparing Your Manuscript (section 6) guidelines below to prepare the manuscript, figures, and tables.

If you have any questions about publishing with Sage, please visit the Sage Journal Solutions Portal

Please read the Manuscript Submission Guidelines below before submitting your manuscript here: 



  1. Open Access
  2. Article processing charge (APC)
  3. What do we publish?
    3.1 Aims & scope
    3.2 Article types
    3.3 Writing your paper
    3.3.1 Making your article discoverable 
  4. Editorial policies
    4.1 Peer Review Policy
    4.2 Authorship
    4.3 Acknowledgements
    4.4 Funding
    4.5 Declaration of conflicting interests
    4.6 Research ethics and patient consent
    4.6.1 Use of Animal- and Human- derived tissue
    4.7 Clinical Trials
    4.8 Reporting guidelines
    4.9 Research data
  5. Publishing policies
    5.1 Publication ethics
    5.1.1 Plagiarism
    5.1.2 Previous publication
    5.2 Contributor's publishing agreement
  6. Preparing your manuscript
    6.1 Word processing formats
    6.2 Artwork, figures and other graphics
    6.3 Supplemental material
    6.4 Reference style
    6.5 English language editing services
  7. Submitting your manuscript
    7.1 How to submit your manuscript
    7.2 Title, keywords and abstracts
    7.3 Information required for completing your submission
    7.3.1 Corresponding author contact details
    7.4 ORCID
    7.5 Information required for completing your submission
    7.6 Permissions
  8. On acceptance and publication
    8.1 Sage Production
    8.2 Continuous publication
    8.3 Promoting your article
  9. Further information


1. Open Access

Cell Transplantation is an open access, peer-reviewed journal. Each article accepted by peer review is
made freely available online immediately upon publication, is published under a Creative Commons
license and will be hosted online in perpetuity. Publication costs of the journal are covered by the
collection of article processing charges which are paid by the funder, institution or author of each
manuscript upon acceptance. There is no charge for submitting a paper to the journal.

For general information on open access at Sage please visit the Open Access page or view our Open
Access FAQs

Back to top

2. Article processing charge (APC)

e-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license.

Please note: The APC for CLL is $2650 USD. Commentary Is free of charge.

The APC is payable upon acceptance after peer review and subject to VAT where applicable.

Back to top

3. What do we publish?

3.1 Aims & scope

Before submitting your manuscript to Cell Transplantation, please ensure you have read the Aims & Scope.

3.2 Article types

On the first page should be the abstract (a maximum of 300 words) and 4-6 keywords. All tables should be placed at the end of the file and numbered in the order they appear in the text. We strongly encourage the appropriate use of bar charts and line graphs to illustrate key findings. Figures should be placed in individual files (we accept TIFF, JPEG, and eps), separate
from the main document file.

Article types published by Cell Transplantation are given below; certain article types observe limits on words and in-text tables. Please see below. Word limits include tables, but not abstracts, key words, or references.

Original Research – Original Research articles are full-length papers that present high-quality research investigations with novelty and significant scientific contributions. We recognize that these can be useful resources for the research community and can play an important role in scientific advancement and addressing the issue of publication bias. We also encourage the submission of negative or null findings of well-conducted studies. An Original Research article generally should have no less than 5 display items (main figures and tables). 
An Original Article contains the following sections: Abstract, Introduction, Materials and Methods, Results, Discussion.

Review – Review articles may be of any length, including figures (schematics), and are peer-reviewed. A Review should not only summarize, highlight, and critique recent literatures but also synthesize and illustrate conceptual frameworks on a topic of broad interest in cell transplantation and its applications to human diseases.
A Review contains the following sections: Abstract, Introduction, Main Text, Conclusion. 

Case Study – Case Studies submitted to Cell Transplantation should report novel cases that have not been well studied or where any similar cases have not been published. Authors should follow the CARE guidelines and provide the CARE checklist as an additional file. The author should seek written and signed consent to publish the information from the patient or their guardian before submitting a Case Study. The submitted manuscript must include a statement that this consent was obtained.
A Case Study contains the following sections: Abstract, Introduction, Case Presentation, Discussion.

Letter to the Editor – A Letter is to provide a rapid and concise report that is within the journal's scope and of particular interest to the community but not suitable as a standard research article. A Letter should be no more 1500 words and no more than 15 references, and only one display item. Additional display items may be published online as Supplemental Information. The information on materials and methods is not required but could be submitted as a supplement. 
A Letter contains the following sections: Abstract, Main Text.

Commentary – Commentary articles publish discussions on publicly interested issues that have broad impacts on cell transplantation research field (e.g., policies, regulations, ethics, etc.) or relevant scientific issues that have significant impacts on future research of regenerative medicine. A Commentary article should have no more than 1,500 words in the main text, with a maximum of 1 display item and up to 15 references. Commentary articles are not charged APCs. 
A Commentary contains the following sections: Abstract, Main Text.

All article types require the following sections:

  • Research ethics and patient consent
  • Availability of data and material
  • Declaration of conflicting interests
  • Funding
  • Authors' contributions
  • Acknowledgements

If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.

Cell Transplantation uses the Council of Science Editors (citation-sequence) style for formatting
citations and the reference list.

3.3 Writing your paper

The Sage Author Gateway has some general advice and on how to get published, plus links to further resources. Sage Author Services also offers authors a variety of ways to improve and enhance their article including English language editing, plagiarism detection, and video abstract and infographic preparation.

3.3.1 Making your article discoverable 

When writing up your paper, think about how you can make it discoverable. The title,
keywords and abstract are key to ensuring readers find your article through search
engines such as Google. For information and guidance on how best to title your article,
write your abstract and select your keywords, have a look at this page on the Gateway:
How to Help Readers Find Your Article Online

Back to top

4. Editorial policies

4.1 Peer review policy

Following a preliminary triage to eliminate submissions unsuitable for Cell Transplantation, all
papers are sent out for review.

The journal’s policy is to have manuscripts reviewed by two expert reviewers. Cell
Transplantation utilizes a single- anonymize peer review process in which the reviewer’s names and
information is withheld from the author.

Reviewers are expected to not possess any conflicts of interest with the authors and research.
They should review the science objectively and provide recommendations for improvements
where necessary. When aware of relevant published work not being cited, the reviewers should
recommend inclusion of these references. If the reviewer feels that they would be unable to
repeat the study as described, then additional methodological details should be requested. Any
unpublished information read by a reviewer should be treated as confidential.

All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Peer review is
managed by the Cell Transplantation Editorial Office Peer who assigns each submitted
manuscript to appropriate reviewers and, with the input of the Editorial Board, and comments
and recommendations of the reviewers, makes decisions on the eligibility of the article for
publication. Neither the editors nor members of the editorial board are involved in the peer review
process for manuscripts authored by themselves or colleagues at their own institutions. 

4.2 Authorship

Papers should only be submitted for consideration once consent is given by all contributing
authors. Those submitting papers should carefully check that all those whose work contributed
to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all
those who:

(i) Made a substantial contribution to the concept or design of the work; or acquisition,
analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public
responsibility for appropriate portions of the content.

Authors should meet the conditions of all of the points above. Each author should have
participated sufficiently in the work to take public responsibility for appropriate portions of the

When a large, multicentre group has conducted the work, the group should identify the
individuals who accept direct responsibility for the manuscript. These individuals should fully
meet the criteria for authorship.

Acquisition of funding, collection of data, or general supervision of the research group alone
does not constitute authorship, although all contributors who do not meet the criteria for
authorship should be listed in the Acknowledgments section. Please refer to the International
Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on

The reported research must be novel and authentic and the authors should confirm that the
same data has not been and is not going to be submitted to another journal (unless already
rejected). Statements made in the introduction and discussion should be supported by
appropriate references and sufficient experimental detail should be provided to allow for
repetition of the study by another group. Plagiarism of the text/data will not be tolerated and
could result in retraction of an accepted article. Any text or figures reproduced for another
source require the permission of the original copyright holders (normally the publishers).

Any manipulation of figures should be equally applied and described in the text including
pseudo-coloring and must not change the meaning of the figure.

When humans, animals or tissue derived from them have been used, then mention of the
appropriate ethical approval must be included in the manuscript.

Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.

4.3 Acknowledgements

All contributors who do not meet the criteria for authorship should be listed in an
Acknowledgements section. Examples of those who might be acknowledged include a person
who provided purely technical help, or a department chair who provided only general support.
Financial support and conflicts of interest for all authors must be declared. Further information
on this can be obtained from the International Committee for Medical Journal Editors
Please acknowledge any funding support. In addition, all authors need to disclose any conflicts
of interest, financial or otherwise, in a separate section before the references. Conflicts of
interest may include: 

1. Direct ownership of equity or shares in a health care or pharmaceutical company
relating to the manuscript, by any author or their immediate family members.
2. Receipt of any form of income by any author or their immediate family members from
health care or pharmaceutical companies related to the manuscript within the calendar
year preceding original submission.
3. Personal interest such as being an expert witness, public advocate, grantee, consultant,
founder, owner, or employee of a health care or pharmaceutical company related to the

4.3.1 Third party submissions

Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:

•    Disclose this type of editorial assistance – including the individual’s name, company and level of input 
•    Identify any entities that paid for this assistance 
•    Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.

Where appropriate, Sage reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.

4.3.2 Writing assistance

Individuals who provided writing assistance, e.g. from a specialist communications company, do
not qualify as authors and so should be included in the Acknowledgements section. Authors
must disclose any writing assistance – including the individual’s name, company and level of
input – and identify the entity that paid for this assistance.
It is not necessary to disclose use of language polishing services.

Any acknowledgements should appear first at the end of your article prior to your Declaration of
Conflicting Interests (if applicable), any notes and your References.

4.4 Funding

Cell Transplantation requires all authors to acknowledge their funding in a consistent fashion
under a separate heading. Please visit the Funding Acknowledgements page on the Sage
Journal Author Gateway to confirm the format of the acknowledgment text in the event of
funding, or state that: This research received no specific grant from any funding agency in the
public, commercial, or not-for-profit sectors.

4.5 Declaration of conflicting interests

It is the policy of Cell Transplantation to require a declaration of conflicting interests from all
authors enabling a statement to be carried within the paginated pages of all published articles.

Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of
your manuscript, after any acknowledgements and prior to the references. If no conflict exists,
please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

In addition, there are sections for detailing any conflicts of interest and financial support and
that you (as corresponding/submitting author) have the permission of the other authors to
submit the manuscript.

For guidance on conflict of interest statements, please see the ICMJE recommendations.

4.6 Research ethics and patient consent

Medical research involving human subjects must be conducted according to the World Medical
Association Declaration of Helsinki

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct,
Reporting, Editing, and Publication of Scholarly Work in Medical Journals

All papers reporting animal and/or human studies must state in both the Methods section and in
the ethical statements (following the Conclusion, before the References) that the relevant Ethics
Committee, Institutional Review Board (IRB), or Institutional Animal Care and Use Committee
(IACUC) provided (or waived) approval. Please ensure that you have provided the full name and
institution of the review committee, in addition to the approval number.

  • Please address the following statements. Please refer to the sample statements in this
    template (Word doc) to help you decide which statement is applicable for your work.
    Include these at the end of your manuscript directly in the document.
  • Ethical Approval
  • Statement of Human and Animal Rights
  • Statement of Informed Consent
  • For research articles, case reports, and other relevant articles, authors
    are required to state whether participants provided informed consent
    for patients information and images to be published and whether the
    consent was written or verbal or provided by a legally authorized

Information on informed consent to report individual cases or case series should be included in the
manuscript text. A statement is required regarding whether written informed consent for patient
information and images to be published was provided by the patient(s) or a legally authorized
representative. Please do not submit the patient’s actual written informed consent with your article, as
this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing,
that you have obtained written informed consent but the written consent itself should be held by the
authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may
be uploaded with your submission as a separate file.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants

4.6.1 Use of Animal- and Human- derived tissue

Please confirm within the text that the appropriate ethical and/or regulatory body approved the
use of animal- or human-derived tissue (as well as informed consent for humans). With human
derived data, articles are published on the understanding that appropriate measures to protect
the privacy of the individuals were undertaken.

4.7 Clinical trials

Cell Transplantation conforms to the ICMJE requirement that clinical trials are registered in a
WHO-approved public trials registry at or before the time of first patient enrolment as a
condition of consideration for publication. The trial registry name and URL, and registration
number must be included at the end of the abstract.

4.8 Reporting guidelines

The relevant EQUATOR Network reporting guidelines should be followed depending on the type
of study. For example, all randomized controlled trials submitted for publication should include
a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should
be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses
should include the completed PRISMA flow chart as a cited figure and the completed
PRISMA checklist should be uploaded with your submission as a supplementary file. The
EQUATOR wizard can help you identify the appropriate guideline.

Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

4.9 Research data

The journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages.

Subject to appropriate ethical and legal considerations, authors are encouraged to:

  • share your research data in a relevant public data repository
  • include a data availability statement linking to your data. If it is not possible to share your data, we encourage you to consider using the statement to explain why it cannot be shared.
  • cite this data in your research

Back to top

5. Publishing policies

5.1 Publication ethics

Sage is committed to upholding the integrity of the academic record. We encourage authors to
refer to the Committee on Publication Ethics’ International Standards for Authors and view the
Publication Ethics page on the Sage Author Gateway.

5.1.1 Plagiarism

Cell Transplantation and Sage take issues of copyright infringement, plagiarism or other
breaches of best practice in publication very seriously. We seek to protect the rights of our
authors and we always investigate claims of plagiarism or misuse of published articles. Equally,
we seek to protect the reputation of the journal against malpractice. Submitted articles may be
checked with duplication-checking software. Where an article, for example, is found to have
plagiarized other work or included third-party copyright material without permission or with
insufficient acknowledgement, or where the authorship of the article is contested, we reserve
the right to take action including, but not limited to: publishing an erratum or corrigendum
(correction); retracting the article; taking up the matter with the head of department or dean of
the author's institution and/or relevant academic bodies or societies; or taking appropriate legal

5.1.2 Prior publication

If material has been previously published, it is not generally acceptable for publication in a Sage
journal. However, there are certain circumstances where previously published material can be
considered for publication. Please refer to the guidance on the Sage Author Gateway or if in
doubt, contact the Editor at the address given below.

5.2 Contributor's publishing agreement

Before publication Sage requires the author as the rights holder to sign a Journal Contributor’s
Publishing Agreement. Cell Transplantation publishes manuscripts under Creative Commons
The standard license for the journal is Creative Commons by Attribution NonCommercial
(CC BY-NC), which allows others to re-use the work without permission as long as
the work is properly referenced and the use is non-commercial. For more information, you are
advised to visit Sage's OA licenses page.

Alternative license arrangements are available, for example, to meet particular funder
mandates, made at the author’s request. 

Back to top

6. Preparing your manuscript

6.1 Word processing formats

Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. Papers
should be typed in English, double-spaced throughout with at least 3-cm margins on paper 
approximately 22 ´ 28 cm (8 1/2 ´ 11 in.) in size. Please consult the most recent issue of the
journal for style and format. Number all pages consecutively, beginning with the title page. Use
metric units of measure; other units may be given in parentheses. Typically, only three levels of
headings are recognized. The paper should be organized as follows.

Title Page: The title should be brief and specific. The title page should contain, in the following
order: title, name(s) and affiliation(s) of author(s) including city, state, postal code, and country,
and a suggested running head of not more than 50 characters and spaces. Also indicate which
author will be the corresponding author (i.e., to whom correspondence should be addressed,
with complete mailing address, telephone and fax numbers, and e-mail necessary for sending
proofs). In general, no more than two shared first and/or senior authorships can be considered
and they must be appropriately justified in the letter to the editor at the time of submission. The
rule can be reassessed on a case-by-case basis for manuscripts arising from multicenter
collaborations, but please note that the production office will not liaise with more than two
corresponding authors. In the case of two corresponding authors, the proof will only be sent to
the first mentioned corresponding author.

Abstract: An abstract of 300 words or less should begin on page 2. It should contain a concise
summary of the results, conclusions, and other significant points in the review.

Key words: For the purpose of subject indexing, provide four to six keywords immediately
following the abstract.

Text: Every effort should be made to avoid jargon, to spell out all nonstandard abbreviations the
first time they are used, and to present the contents of the study as clearly and concisely as
possible. In the Materials and Methods section, authors are required to supply sufficient detail
for replication of the study, including the name of the company from which the materials
(reagents and equipment) were supplied and the location of company headquarters (city, state
if in the U.S., and country). References to previously described methods must be properly cited
and also described in moderate detail. References should be given for all discussions and
conclusions of previous studies. Trade names may appear in parentheses and should be
capitalized. Critical discussions of the literature are preferred more than historically oriented

6.2 Artwork, figures and other graphics

Tables: All tables must be created in Microsoft Word. Tables should be numbered and cited
sequentially in the text. Prepare each table as a separate page at the end of the manuscript text,
after the references. Avoid very wide or long tables that would not fit a printed page. Each table
should have a title, and each column in the table should have a brief heading. Define all
abbreviations in the table footnote at the bottom of the table.

Figures: Figures should be numbered and cited sequentially in the text. Each figure should be
provided as a separate file (see Final Accepted Manuscript). Include all parts of a figure (e.g., A,
B, etc.) as one file. Do not use light lettering and shading that will not reproduce well. Figure
dimensions and scaling should be suitable for reduction (if necessary) to fit column or page size.
Care must be taken that letters and other symbols do not become so small that they are illegible
when the figure is reduced. Complex formulas should be prepared as illustrations. (Do not
embed figures within the manuscript text.) Please consult our guide on preparing blots and gels if they will be included in figures. 

Figure Legends: Each figure legend must have a short title that concisely describes the content
of each figure. List all figure legends sequentially on one or more pages at the end of the
manuscript text, after the references, and identify all symbols used in the figures. The figure
legend should be as clear as possible and should fully describe the contents of the figure. (Do
not include the figure legend as part of the figure). If the figure is from a previously published
article, indicate that permission has been obtained from the original publisher.

Figure Files: Each figure should be provided as a separate, high-resolution file. Simple black and
white figures (e.g., line graphs, bar graphs, etc.) should be 1200 dpi. Halftone and color figures
(or combo figures) should be 600 dpi. Final figure files should be submitted as tiff, jpg, or eps
format. Do not include the figure number as part of the figure file (e.g., do not label Figure 1,
etc., as part of the figure). Do not provide color in a figure file unless the figure will be printed in
color (note there is a cost for printing figures in color).

6.3 Supplemental material

This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images
etc) alongside the full-text of the article. These will be subjected to peer-review alongside the
article. For more information please refer to our guidelines on submitting supplementary files,
which can be found within our Manuscript Submission Guidelines page

6.4 Reference style

Literature cited should be prepared according to the Council of Science Editors format (citationsequence)
style. This format is conveniently in Endnote and the output style is available at the
following site:
Some examples are provided below. References in the text should be cited by superscript number separated by a comma and listed in numerical order as they appear in the text (double
spaced) on a separate page at the end of the manuscript. Journal citations in the reference list
should contain the following: (a) reference number NOT in superscript; (b) surnames and initials
of up to the first 11 authors (surnames precede initials); (c) title of article; (d) journal title abbreviated as listed
in; (e) year; volume, inclusive pages. See the examples shown and refer to Council of
Science Editors format for more examples.

Journal Article: Wang Y, Nathanson L, McNiece IK. Differential hematopoietic supportive
potential and gene expression of stroma cell lines from midgestation mouse placenta and adult
bone marrow. Cell Transplant. 2011;20:707–26.

Book Article/Chapter: Taylor MJ, Baicu, S. Hypothermic perfusion of pancreas: Emphasis on
preservation prior to islet isolation. In: Uygun K, Lee CY, editors. Organ preservation and
reengineering. Boston (MA): Artech House Publisher; 2011. p. 85-104.

Book: Wang-Fischer Y. Manual of stroke models in rats, 1st ed. Boca Raton (FL): CRC Press; 2009.

Internet Source: Stem Cell Research Oversight Committee. University of Wisconsin-Madison
policy for multisite research studies using human pluripotent stem cells [Internet]. Madison
(WI): University of Wisconsin-Madison; 2009 [cited 2013 Sep 12]. Available from

An example of an in-text citation is shown below.

Traumatic life events and posttraumatic stress disorder (PTSD) are endemic among American

To cite multiple sources, all numbers associated with the reference being cited should be
superscript, separated by a comma, with no spaces between them.

Statistics: If statistical analysis was performed, define the tests used in the methods and ensure
that it is clear what comparisons are made. Please ensure that appropriate testing was
performed when multiple comparisons (i.e., one group compared to more than one other
group) were made.

6.5 English language editing services

Manuscripts should be grammatically correct and completely comprehendible upon submission
before they will be forwarded for peer review.

Authors seeking assistance with English language editing, translation, or figure and manuscript
formatting to fit the journal’s specifications should consider using Sage Language Services. Visit
Sage Language Services on our Journal Author Gateway for further information. 

Back to top

7. Submitting your manuscript

7.1 How to submit your manuscript

Cell Transplantation is hosted on Sage Track, a web based online submission and peer review
system powered by ScholarOne™ Manuscripts. Visit to login and submit your article online.

IMPORTANT: Please check whether you already have an account in the system before trying to
create a new one. If you have reviewed or authored for the journal in the past year it is likely
that you will have had an account created. For further guidance on submitting your manuscript
online please visit ScholarOne Online Help.

7.2 Title, keywords and abstracts

Please supply a title, short title, an abstract and keywords to accompany your article. The title,
keywords and abstract are key to ensuring readers find your article online through online search
engines such as Google. Please refer to the information and guidance on how best to title your
article, write your abstract and select your keywords by visiting the Sage Journal Author
Gateway for guidelines on How to Help Readers Find Your Article Online

7.3 Information required for completing your submission

Provide full contact details for the corresponding author including email, mailing address and
telephone numbers. Academic affiliations are required for all co-authors. These details should
be presented separately to the main text of the article to facilitate anonymous peer review.
You will be asked to provide contact details and academic affiliations for all co-authors via the
submission system and identify who is to be the corresponding author. These details must
match what appears on your manuscript. At this stage please ensure you have included all the
required statements and declarations and uploaded any additional supplementary files
(including reporting guidelines where relevant).

7.3.1 Corresponding author contact details

Provide full contact details for the corresponding author including email, mailing address and
telephone numbers. Academic affiliations are required for all co-authors. These details should
be presented separately to the main text of the article to facilitate anonymous peer review.


As part of our commitment to ensuring an ethical, transparent and fair peer review process Sage
is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a
unique and persistent digital identifier that distinguishes researchers from every other researcher,
even those who share the same name, and, through integration in key research workflows such
as manuscript and grant submission, supports automated linkages between researchers and their
professional activities, ensuring that their work is recognized.

The collection of ORCID IDs from corresponding authors is now part of the submission process of
this journal. If you already have an ORCID iD you will be asked to associate that to your submission
during the online submission process. We also strongly encourage all co-authors to link their ORCID
ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when
prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID
iD will become part of your accepted publication’s metadata, making your work attributable to you
and only you. Your ORCID iD is published with your article so that fellow researchers reading your
work can link to your ORCID profile and from there link to your other publications.

If you do not already have an ORCID ID please follow this link to create one or visit our ORCID homepage
to learn more.

      7.5 Information required for completing your submission

       You will be asked to provide contact details and academic affiliations for all co-authors via the
       submission system and identify who is to be the corresponding author. These details must match what
       appears on your manuscript. The affiliation listed on the manuscript should be the institution where the
       research was conducted. If an author has moved to a new institution since completing the research, the
       new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure
       you have included all the required statements and declarations and uploaded any additional
       supplementary files (including reporting guidelines where relevant).

7.6 Permissions

Authors are responsible for obtaining permission from copyright holders for reproducing any
illustrations, tables, figures or lengthy quotations previously published elsewhere. For further
information including guidance on fair dealing for criticism and review, please visit our
Frequently Asked Questions on the Sage Journal Author Gateway.

Back to top

8. On acceptance and publication

If your paper is accepted for publication after peer review, you will first be asked to complete the
contributor’s publishing agreement. All material accepted for publication is subject to copyediting.
Authors will receive page proofs of articles before publication, along with an APC authorization form
(with the final cost based on the number of printed pages) and Color Figure authorization form (if there
are potential color figures), which will need to be completed and returned before the article can be
processed for publication. Note that if the figures were originally in color but you decide not to print in
color at proof stage the text/legends may need to be modified to reflect this change. Please note that if
the lack of color makes the figure difficult to interpret then revised figures (or agreement to pay for
color) may be required.

8.1 Sage Production

Your Sage Production Editor will keep you informed as to your article’s progress through out the production process. Proofs will made available to the corresponding author via our editing portal Sage Edit, or by email to the corresponding author and should be returned promptly.  Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. 

8.2 Online publication

One of the many benefits of publishing your research in an open access journal is the speed to
publication. With no page count constraints, your article will be published online in a fully
citable form with a DOI number as soon as it has completed the production process. At this time
it will be completely free to view and download for all. 

8.3 Promoting your article

Publication is not the end of the process! You can help disseminate your paper and ensure it is
as widely read and cited as possible. The Sage Author Gateway has numerous resources to help
you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.

Back to top

9. Further information

Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Deputy Editor-in-Chief, Ying Lou,

Back to top